marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
InMed Pharmaceuticals Income Statement 2011-2024 | INM
Annual Income Statement InMed Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.71 M | 3.02 M | 269 K | 46.7 M | - | - | - | - | - | - | - | - | - |
Shares |
2.45 M | 561 K | 269 K | 5.22 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
0.7 | 5.39 | 1.21 | 4.21 | 8.91 | 16.1 | 31.3 | 8.48 | 4.29 | 2.97 | - | - | - |
Net Income |
-7.95 M | -18.6 M | -10.2 M | -11.9 M | -13.3 M | -8.52 M | -4.47 M | -2.38 M | -4.29 M | -1.23 M | -49.2 K | -193 K | -315 K |
Revenue |
4.14 M | 1.09 M | 1.9 M | - | - | - | - | - | - | - | - | - | 38.4 K |
Cost of Revenue |
2.42 M | 546 K | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
1.4 M | 544 K | - | - | - | - | - | - | - | - | - | - | 38.4 K |
Operating Income |
-7.95 M | -18.6 M | -10.2 M | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
431 K | -1.34 M | -360 K | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-7.75 M | -18.4 M | -10.1 M | -11.9 M | -13.5 M | -8.49 M | -4.38 M | -2.29 M | -4.2 M | -1.23 M | -49.2 K | -171 K | -244 K |
Operating Expenses |
9.78 M | 17.8 M | 9.94 M | 8.87 M | 10.4 M | 6.55 M | 3.44 M | 1.84 M | 3.46 M | 1.15 M | 46.7 K | 169 K | 427 K |
General and Administrative Expenses |
369 K | 290 K | 4.48 M | 3.5 M | 6 M | 4.99 M | 2.79 M | 1.48 M | 2.62 M | 1.09 M | 46.7 K | - | 287 K |
All numbers in USD currency
Quarterly Income Statement InMed Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
620 K | 446 K | 7.97 M | 166 K | 3.33 M | 3.33 M | 2.3 M | 866 K | 651 K | 566 K | 554 K | 482 K | 517 K | 7.55 M | 6.09 M | 5.22 M | 6.09 M | 5.22 M | 5.22 M | 5.22 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-1.68 M | - | -1.48 M | -2.54 M | - | -2 M | -2.1 M | -3.51 M | -5.61 M | -3.48 M | -4.28 M | -2.97 M | -7.25 M | -3.1 M | -2.24 M | -1.6 M | -2.24 M | -1.6 M | -2.49 M | -2.81 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
1.26 M | - | 1.24 M | 902 K | - | 1.03 M | 470 K | 321 K | 791 K | 310 K | 265 K | 1.02 M | 265 K | 437 K | 277 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
771 K | - | 746 K | 881 K | - | 841 K | 339 K | 235 K | 574 K | 127 K | 154 K | - | 154 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
493 K | - | 324 K | 21.2 K | - | 193 K | 131 K | -491 K | -360 K | 182 K | 112 K | - | 112 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | - | - | - | - | -2 M | -2.1 M | -3.51 M | -5.61 M | -3.48 M | -4.28 M | -2.97 M | -7.25 M | -3.1 M | -2.24 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | -1.5 K | -3 K | -6.8 K | -9.8 K | - | - | -360 K | - | - | -360 K | - | -360 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | - | - | -1.95 M | -2.05 M | -3.46 M | -5.51 M | -3.42 M | -4.23 M | -2.94 M | -7.18 M | -3.07 M | -2.21 M | 28 K | 64.8 K | 28 K | 28.2 K | 30.2 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
2.23 M | - | 1.97 M | 2.69 M | - | 2.34 M | 2.35 M | 2.99 M | 5.35 M | 3.72 M | 4.42 M | 2.89 M | 7.32 M | 3.13 M | 1.93 M | 1.56 M | 1.93 M | 1.56 M | 2.51 M | 2.88 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
1.42 M | - | 10.1 K | 1.3 M | - | 1.41 M | 44 K | 1.56 M | 3.03 M | 1.92 M | 1.84 M | 1.37 M | 3.21 M | 1.33 M | 960 K | 625 K | 960 K | 625 K | 872 K | 888 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency